x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

science medicine

All Episodes

86:59

What Clinicians Want to Know: Addressing Current...

Hematologic Oncology Update ·

2025/01/09

Prof Andreas Hochhaus from Jena University Hospital in Germany, Dr B Douglas Smith from the Sidney Kimmel Comprehensive Cancer Center at John Hopkins in Baltimore, Maryland, and Dr Michael J Mauro from Memorial Sloan Kettering Cancer Center in New York, New York, discuss recent updates on available and novel treatment strategies for chronic myeloid leukemia.

en

118:50

What Clinicians Want to Know: Addressing Current...

Hematologic Oncology Update ·

2025/01/07

Dr Alexander Perl from Abramson Cancer Center in Philadelphia, Pennsylvania, Dr Richard M Stone from Dana-Farber Cancer Institute in Boston, Massachusetts, Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, Prof Andrew H Wei from Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, and moderator Dr Eytan M Stein from Memorial Sloan Kettering Cancer Center in New York, New York, discuss updated data from ASH 2024 influencing the current and

en

117:10

What Clinicians Want to Know: Addressing Current...

Hematologic Oncology Update ·

2024/12/21

Prof Philippe Moreau of University Hospital – CHU de Nantes in France, Dr Robert Z Orlowski of The University of Texas MD Anderson Cancer Center in Houston, Dr Noopur Raje of Massachusetts General Hospital Cancer Center in Boston, Dr Paul G Richardson of Dana-Farber Cancer Institute in Boston, and Dr Sagar Lonial of Winship Cancer Institute of Emory University in Atlanta, Georgia, discuss current questions and controversies in the management of multiple myeloma.

en

117:07

What Clinicians Want to Know: Addressing Current...

Hematologic Oncology Update ·

2024/12/19

Dr Farrukh Awan from Harold C Simmons Comprehensive Cancer Center in Dallas, Texas, Dr Bita Fakhri from Stanford University School of Medicine in California, Dr Kerry A Rogers from the Ohio State University in Columbus, Dr William Wierda from the University of Texas MD Anderson Cancer Center in Houston, and moderator Dr Jeff Sharman from the Sarah Cannon Research Institute discuss updated data from ASH 2024 influencing the current and future treatment paradigm for treatment-naïve and

en

51:43

Cases from the Community: Integrating New Research...

Hematologic Oncology Update ·

2024/12/17

Dr Stephen T Oh shares his perspectives on the evolving therapeutic landscape for patients with myelofibrosis.

en

51:44

Cases from the Community: Integrating New Research...

Hematologic Oncology Update ·

2024/12/13

Dr Harry Paul Erba shares his perspectives on the evolving therapeutic landscape for patients with leukemia and myelodysplastic syndromes.

en

106:37

Practical Perspectives: Investigators Discuss the...

Hematologic Oncology Update ·

2024/12/04

Dr Gloria Gerber, Dr Jamie Koprivnikar, Prof Alexander Röth and Dr Jamile Shammo discuss available and emerging research, patient cases from participating junior clinical investigator faculty and senior clinical investigator faculty perspectives of relevant research data informing clinical decision-making for paroxysmal nocturnal hemoglobinuria.

en

52:45

Data + Perspectives: Clinical Investigators Explore...

Hematologic Oncology Update ·

2024/11/26

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with multiple myeloma.

en

58:36

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2024/11/23

Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, discusses recent updates on available and novel treatment strategies for chronic lymphocytic leukemia.

en

56:11

Data + Perspectives: Clinical Investigators Explore...

Hematologic Oncology Update ·

2024/11/20

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia.

en

56:14

What Clinicians Want to Know About the Current and...

Hematologic Oncology Update ·

2024/11/08

Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma.

en

57:58

Practical Perspectives: Optimizing the Role of BTK...

Hematologic Oncology Update ·

2024/10/30

Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Michael Wang from the University of Texas MD Anderson Cancer Center in Houston discuss the current role of Bruton tyrosine kinase inhibitors for the management of newly diagnosed and relapsed/refractory mantle cell lymphoma.

en

109:21

Practical Perspectives: Current Management of Chronic...

Hematologic Oncology Update ·

2024/10/24

Drs Bhavana (Tina) Bhatnagar, Amanda Blackmon, Jorge Cortes, Michael J Mauro and Neil P Shah discuss recent updates on clinical treatment strategies for chronic myeloid leukemia.

en

46:32

Oncology Today with Dr Neil Love: Peripheral T-Cell...

Hematologic Oncology Update ·

2024/10/17

Dr Stephen Horwitz from Memorial Sloan Kettering Cancer Center in New York, New York, discusses management strategies for previously untreated and relapsed peripheral T-cell lymphomas.

en

58:58

Meet The Professor: Optimizing the Management of...

Hematologic Oncology Update ·

2024/10/10

Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational treatment approaches for chronic lymphocytic leukemia.

en

62:03

Year in Review: Clinical Investigator Perspectives on...

Hematologic Oncology Update ·

2024/08/12

Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.

en

60:49

RTP Live from Chicago: Investigator Perspectives on...

Hematologic Oncology Update ·

2024/07/12

Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas.

en

60:06

Year in Review: Clinical Investigator Perspectives on...

Hematologic Oncology Update ·

2024/07/02

Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis.

en

76:45

Oncology Today with Dr Neil Love: Key Presentations...

Hematologic Oncology Update ·

2024/05/29

Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.

en

33:54

Oncology Today with Dr Neil Love: Recent Advances in...

Hematologic Oncology Update ·

2024/05/28

Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

en

601 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter